Drug Name Identification an Ignored Patient's Problem That Needs a Solution
NCT05343234 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500
Last updated 2022-04-25
Summary
Each of the recruited patient was given 3 different placebo drugs with 3 different mad up names to be taken for one month with different regiments.
The drug name resembled a real drug but with enough difference to prevent the patient from trying to buy it as a safety precaution. The name was printed on the box in English and Arabic letters. The coloured shape was printed to 2x2 cm dimension.
After one month the participants were intervened by a doctor blinded to the study. The doctor asked about the drug history of the patient. If the participant could remember the drug name and its correct regiment the doctor documented that. if the patent failed to remember the correct name and its regiment then the doctor asked the patient to try and remember anything about the drug.
Then the patient would be asked about the symbol on the drug and was it helpful for him in any way.
Conditions
- Remember the Name of a Given Drug
Interventions
- DRUG
-
tree different placebo drugs with tree different names and scheduled will be given
Sponsors & Collaborators
-
Alexandria University
lead OTHER
Principal Investigators
-
yasser M osman · Alexandria University
Study Design
- Allocation
- NA
- Purpose
- SCREENING
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-04-01
- Primary Completion
- 2022-06-30
- Completion
- 2022-06-30
Countries
- Egypt
Study Locations
More Related Trials
-
Measuring Placebo Effect by Elimination and Investigating Mechanism of Action
NCT00426010 ·Status: COMPLETED ·Phase: NA
-
Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dyslexia
NCT00111371 ·Status: UNKNOWN ·Phase: PHASE4
-
Use of 3,4-Diaminopyridine in the Treatment of Lambert-Eaton Syndrome
NCT01825395 ·Status: APPROVED_FOR_MARKETING
-
Dazucorilant in Patients With Amyotrophic Lateral Sclerosis
NCT05407324 ·Status: RECRUITING ·Phase: PHASE2
-
Dextromethorphan to Treat Patients With Voice Spasms
NCT00055549 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety and Effectiveness of Cholinergic Receptor Block Therapy in the Treatment of ALS
NCT04391361 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.
NCT03196375 ·Status: TERMINATED ·Phase: PHASE2
-
Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
NCT03082755 ·Status: RECRUITING ·Phase: PHASE4
-
The Effect of Platelet-rich Plasma Nasal Injection in the Treatment of Traumatic Olfactory Dysfunction
NCT06290219 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome
NCT00004832 ·Status: COMPLETED ·Phase: NA
-
Four Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Legs Syndrome
NCT00135993 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of RLS Symptoms
NCT00389831 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Amisodin in Healthy Adult Subjects With Amyotrophic Lateral Sclerosis
NCT07221240 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Determine the Safety, Pharmacokinetics, and Pharmacodynamics of DNL343 in Participants With Amyotrophic Lateral Sclerosis
NCT05006352 ·Status: COMPLETED ·Phase: PHASE1
-
Colchicine for Amyotrophic Lateral Sclerosis
NCT03693781 ·Status: COMPLETED ·Phase: PHASE2
-
Memantine for Enhanced Stroke Recovery
NCT02144584 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Study of SPM 962 in Patients With Restless Legs Syndrome (RLS)
NCT01084551 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial Assessing the Efficacy and Safety of BP1.4979 in Restless Legs Syndrome
NCT03345953 ·Status: TERMINATED ·Phase: PHASE2
-
Rotigotine Restless Legs Syndrome Dose Finding Trial
NCT00243217 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Dexamethasone for the Treatment of Cervical Radiculopathy
NCT00308594 ·Status: TERMINATED ·Phase: PHASE2
-
A Clinical Pharmacology Study to Evaluate the Effect of GYM329 on Disuse Muscle Atrophy in Healthy Volunteer
NCT04708847 ·Status: COMPLETED ·Phase: PHASE1
-
Pyridostigmine and Its Effects on Autonomic Modulation in Diabetic Patients
NCT00953914 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Pharmacodynamics of VK0214 in Male Subjects With AMN
NCT04973657 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Deutetrabenazine to Control Symptoms of Dysphagia Associated with HD
NCT04301726 ·Status: TERMINATED ·Phase: PHASE1
-
ASP8825 - Study in Patients With Restless Legs Syndrome
NCT00530530 ·Status: COMPLETED ·Phase: PHASE2